Lexaria Bioscience
Price & Volume
Stats
See more52W Range | $2.77-$21.60 |
Market Cap | $6.7M |
Shares Short | 179,002 |
Financials
See moreRevenue (12 Mos) | $194,000 |
Revenue Growth (YoY) | -88.5% |
Gross Profit (12 Mos) | $194,000 |
Diluted EPS | -$5.10 |
News
See moreYahoo Finance • 2 months ago
Lexaria Announces Effective Date for Reverse Stock Split
Yahoo Finance • 4 months ago
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
Yahoo Finance • 4 months ago
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
Yahoo Finance • 5 months ago
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
About
CEO | Mr. Richard C. Christopher |
Address | 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |